Modeling muscle regeneration in RNA toxicity mice.

Area of Science:

• Molecular Biology
• Muscle Physiology
• Genetics

Background:

• RNA toxicity is implicated in myotonic dystrophy type 1 (DM1) pathogenesis, contributing to muscular dystrophy.
• The precise mechanisms linking RNA toxicity to muscular dystrophy in DM1 remain incompletely understood.

Purpose of the Study:

• To investigate the impact of RNA toxicity on skeletal muscle regeneration using a DM1 mouse model.
• To evaluate the therapeutic potential of a novel antisense oligonucleotide targeting DMPK mRNA in DM1.

Main Methods:

• Utilized the DM200 mouse model expressing mutant DMPK 3'UTR mRNA to study RNA toxicity.
• Employed a BaCl2-induced muscle damage model to assess regenerative capacity and satellite cell dynamics.
• Administered a ligand-conjugated antisense oligonucleotide (IONIS 877864) targeting DMPK 3'UTR mRNA.

Main Results:

• RNA toxicity reduced PAX7 expression and satellite cell (MuSC) numbers, delaying muscle regeneration and maturation.
• Repeated muscle damage in the model induced dystrophic changes, including fibrosis and fat droplet deposition.
• Antisense oligonucleotide treatment successfully corrected regenerative deficits and restored satellite cell populations.

Conclusions:

• RNA toxicity directly impairs skeletal muscle regeneration and satellite cell maintenance in DM1.
• Antisense oligonucleotide therapy targeting DMPK mRNA shows promise for treating muscular dystrophy in DM1.